Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Preclinical Development: Overview01:28

Preclinical Development: Overview

5.7K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.7K
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

1.8K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.8K
In Vitro Drug Release Testing: Overview, Development and Validation01:10

In Vitro Drug Release Testing: Overview, Development and Validation

286
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
286

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of Maternal Tetramethyl Bisphenol F Exposure on Neurodevelopment and Behavior in Mouse Offspring.

International journal of molecular sciences·2026
Same author

Tetramethyl Bisphenol F: Organ- and System-Specific Toxicity, Current Status, and Perspectives.

International journal of molecular sciences·2025
Same author

Effects of TBBPA Exposure on Neurodevelopment and Behavior in Mice.

International journal of molecular sciences·2025
Same author

Embryoid Body Test: A Simple and Reliable Alternative Developmental Toxicity Test.

International journal of molecular sciences·2025
Same author

Mitochondrial Toxic Effects of Antiepileptic Drug Valproic Acid on Mouse Kidney Stem Cells.

Toxics·2023
Same author

Effects of Decamethylcyclopentasiloxane on Reproductive Systems in Female Rats.

Toxics·2023
Same journal

<i>Actinobacillus pleuropneumoniae</i> in Korea (2015-2025): serovar distribution, toxin gene profiles, antimicrobial resistance, and identification of an apxIICA-deficient serovar 15 profile.

Journal of veterinary science·2026
Same journal

Simulation, artificial intelligence, and competency-based frameworks in veterinary medical education: a narrative review.

Journal of veterinary science·2026
Same journal

Basic fibroblast growth factor preserves rabbit adipose-derived mesenchymal stromal cells in serum-free culture.

Journal of veterinary science·2026
Same journal

Behavioral characterization of olfactory, auditory, and motor deficits in 5×FAD mice.

Journal of veterinary science·2026
Same journal

<i>Clostridium perfringens</i> in Korean pig farms: antimicrobial resistance and toxin profiles.

Journal of veterinary science·2026
Same journal

Risk factors for early and mid-to-late pregnancy loss and their effects on reproductive performance in dairy cows.

Journal of veterinary science·2026
See all related articles

Related Experiment Video

Updated: Jan 9, 2026

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation
17:28

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation

Published on: June 17, 2015

13.1K

Alternative methods for developmental toxicity testing: features, status and future directions.

Inho Hwang1, Eui-Bae Jeung2

  • 1Laboratory of Veterinary Biochemistry and Molecular Biology, College of Veterinary Medicine, Chungbuk National University, Cheongju 28644, Korea.

Journal of Veterinary Science
|December 3, 2025
PubMed
Summary
This summary is machine-generated.

New alternative methods offer ethical and efficient ways to assess developmental toxicity, moving beyond traditional animal testing. These approaches enhance drug safety evaluations and protect public health.

Keywords:
In vitro techniquesbiological assaycomputational biologyorganoidsrisk assessment

More Related Videos

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
05:45

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells

Published on: October 10, 2025

470
Rapid Evaluation of Toxicity of Chemical Compounds Using Zebrafish Embryos
07:49

Rapid Evaluation of Toxicity of Chemical Compounds Using Zebrafish Embryos

Published on: August 25, 2019

11.4K

Related Experiment Videos

Last Updated: Jan 9, 2026

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation
17:28

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation

Published on: June 17, 2015

13.1K
Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
05:45

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells

Published on: October 10, 2025

470
Rapid Evaluation of Toxicity of Chemical Compounds Using Zebrafish Embryos
07:49

Rapid Evaluation of Toxicity of Chemical Compounds Using Zebrafish Embryos

Published on: August 25, 2019

11.4K

Area of Science:

  • Developmental toxicology
  • Regulatory science
  • In vitro toxicology

Background:

  • Early development is critical and sensitive to toxic effects.
  • Traditional animal testing for developmental toxicity has limitations (cost, ethics, species differences).
  • There is a growing need for reliable alternative methods in drug and chemical safety assessment.

Purpose of the Study:

  • To review current alternative methods for developmental toxicity testing.
  • To examine institutional efforts in adopting these new approaches.
  • To discuss future directions in the field.

Main Methods:

  • Review of new approach methodologies (NAMs) including embryoid body tests, organoids, and zebrafish models.
  • Integration of in vitro data with predictive models, such as machine learning.
  • Examination of regulatory body initiatives (e.g., OECD) promoting method acceptance.

Main Results:

  • Alternative methods like embryoid body tests and organoids provide faster, reproducible, and human-relevant toxicity assessments.
  • Zebrafish models offer validated endpoints for morphological and behavioral evaluations.
  • Predictive models enhance mechanism-based analysis when combined with in vitro data.

Conclusions:

  • Alternative methods offer ethical and rational approaches to developmental toxicity assessment.
  • Integration into regulatory science aids early safety decisions in clinical development and public health.
  • Stakeholder collaboration is crucial for broader adoption and guideline revision.